This is the authors' abstract. We don't add key points for this paper.
Double-blind studies have demonstrated that motor complications in Parkinson's disease (PD) can be reduced with continuous delivery of levodopa. The DopaFuse system is a novel, intraoral micropump that attaches to a retainer and uses a propellant to deliver levodopa/carbidopa (LD/CD) continuously into the mouth.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Olanow et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: